Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Royal Biologics has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner and 1 distinct art unit.
CANDELARIA, JULIANA IRENE is the busiest examiner, with 1 pending matter. Counsel can focus on one prosecution record and align the response with the examiner’s treatment of the biological or pharmaceutical claims.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18822397 | SYSTEMS AND METHODS OF ENHANCEMENTS OF THERAPEUTIC PROPERTIES OF A SOLID GRAFT MATERIAL | CANDELARIA, JULIANA IRENE | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18822397 | SYSTEMS AND METHODS OF ENHANCEMENTS OF THERAPEUTIC PROPERTIES OF A SOLID GRAFT MATERIAL | CANDELARIA, JULIANA IRENE | 1634 | §103§112 | Non-Final OA | — | Pending | Sep 02, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRoyal Biologics has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Juliana Irene Candelaria has the most, with 1 of Royal Biologics's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.